About Endocrinology and Metabolic Disorders
- Home |
- About Endocrinology and Metabolic Disorders
The International Conference and expo on Endocrinology and Metabolic Disorders will be held April 13-14, in Virtually under the auspices of Hilaris Conferences.
All endocrinologists, diabetologists, and other medical & clinical professionals working in the field of endocrinology and metabolic syndrome are cordially invited to the forthcoming Endocrinology 2023.
Benefits for young scientists:
Oral presentations at our conferences offer the best platform for your research.
Discuss the concepts with mentors and prominent scholars.
The winners of the Young Scientist Award will receive certificates and mementos.
Through this Forum, young scientists will receive pertinent and current information.
Platform for young researchers to collaborate for improved development.
Award should encourage participants to work hard to reach their full potential, which could benefit the industry as a whole.
Why To Attend:
The Endocrinology 2023 conference brings together leading researchers, academics, scientists, professors, endocrinologists, diabetologists, nutritionists, doctors, nurse practitioners, and others from the healthcare industry to interact and exchange ideas about cutting-edge technologies in the fields of endocrinology and diabetes. The meeting will also offer an informed view of the problems caused by Endocrinology 2023 and the solutions to those problems in the future. Endocrinology 2023 offers the chance to meet with renowned scientists, academics, business leaders, and subject matter experts from around the world. Endocrinology 2023's modest efforts will enable the area of healthcare to advance significantly.
Endocrinology 2023 highlights include:
The Endocrinology 2023 conference will be useful to participants from both the Industry and Academia working in all the domains of Health care sectors, all other target audience includes:
Due to the rising prevalence of endocrine illnesses, the market for endocrinology medications is predicted to grow profitably over the forecast period. Acromegaly, thyroiditis, Addison's disease, gigantism, goitre, Cushing's syndrome, polycystic ovarian syndrome (PCOS), osteomalacia, diabetes, hypertension, and hyperlipidemia are among the conditions that fall under this category. The growing adolescent population, which is more susceptible to these illnesses as a result of hormonal imbalances, also tends to fuel the demand for endocrinology medications. The development of new drug delivery systems, in-depth research and development, and an increase in disposable income, along with unhealthy lifestyle factors like high cholesterol intake, work stress, and weight gain that ultimately cause endocrine system dysfunction, drive the market for endocrinology drugs to grow.